Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardiology
MedTech
Acquisitive Boston Scientific sees growth rate ease in Q3
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year.
Ben Adams
Oct 22, 2025 10:05am
Cell lines could lead to new drugs for deadly heart condition
Jun 4, 2024 2:12pm
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
May 13, 2024 9:36am
Imbria hits safety benchmark in phase 2 heart failure test
Nov 7, 2023 9:55am
Fallout from Quantum Genomics' phase 3 fail claims executives
Feb 22, 2023 2:06pm
Ultrasound AI outperforms human clinicians in randomized study
Aug 27, 2022 3:40pm
